Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00608023 at 2026-07-30T19:35:26.307Z. Its registry update date was 2022-09-30, and PeptideScanner's reviewed identity mapping was tesamorelin.↗
PeptideScanner retained ClinicalTrials.gov record NCT00608023 at 2026-07-30T19:35:26.307Z. Its registry update date was 2022-09-30, and PeptideScanner's reviewed identity mapping was tesamorelin. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1
Exact identifier graph
This graph reports exact NCT and PMID identifiers declared in structured PubMed or ClinicalTrials.gov metadata for records already selected by PeptideScanner. A link or source reference type does not establish study quality, article findings, safety, effectiveness, regulatory approval, or a complete publication history.
Declared by both sources
Declared by both sources
Complete submitted registry timeline
ClinicalTrials.gov lists these public versions with submitted dates from January 23, 2008 through September 16, 2022. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.
Source-declared changed modules: None listed for this version
Source-declared changed modules: Study Identification, Study Status
Source-declared changed modules: Arms and Interventions, Outcome Measures, Sponsor/Collaborators, Study Design, Study Status
Source-declared changed modules: Adverse Events, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Status
Source-declared changed modules: Adverse Events, Arms and Interventions, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Design, Study Status
Source-declared changed modules: Outcome Measures (Results), Study Status
Source-declared changed modules: Adverse Events, More Information, Study Description, Study Identification, Study Status
Source-declared changed modules: Contacts/Locations, IPDSharing, Limitations and Caveats, Study Identification, Study Status
ClinicalTrials.gov · Official source · Source checked August 14, 2026